Vascular endothelial growth factor-A165b prevents diabetic neuropathic pain and sensory neuronal degeneration
Hulse RP., Beazley-Long N., Ved N., Bestall SM., Riaz H., Singhal P., Ballmer Hofer K., Harper SJ., Bates DO., Donaldson LF.
<jats:p>Systemic treatment of diabetic rats with a novel human growth factor, vascular endothelial growth factor (VEGF)-A165b, reversed neuropathic pain and peripheral nerve damage.</jats:p>